v3.26.1
Temporary Equity and Stockholders’ Equity (Deficit) (Tables)
9 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Unvested Series C Convertible Preferred Stock

 

       Weighted Average 
   Number of   Grant Date 
Non-Vested Shares  Shares   Fair Value 
June 30, 2024   -   $- 
Granted   94,250    0.0068 
Vested   (37,300)   0.0068 
Cancelled/Forfeited   -    - 
June 30, 2025   56,950   $0.0068 
Granted   -      
Vested   (44,383)     
Cancelled/Forfeited   -      
March 31, 2026   12,567   $0.0068 
           
Unrecognized compensation  $512,720      
           
Weighted average remaining period (years)   0.67      
Schedule of Revenue Based Equity Awards

 

Company Revenue   Restricted Stock Award (% of equity) 
      
$50,000,000    3.0%
$100,000,000    3.5%
$150,000,000    4.0%
$200,000,000    4.5%
$300,000,000    5.0%
Schedule of EBITDA Based Equity Awards

 

Company EBITDA   Restricted Stock Award (% of equity) 
      
$1,000,000    2%
$3,000,000    3%
$5,000,000    4%
$10,000,000    5%
$20,000,000    6%
$30,000,000    7%
$50,000,000    8%
$100,000,000    10%
Schedule of Stock Warrant Activity

Warrant activity for the nine months ended March 31, 2026 and the year ended June 30, 2025 are summarized as follows:

 

           Weighted     
           Average     
       Weighted   Remaining   Aggregate 
   Number of   Average   Contractual   Intrinsic 
Warrants  Warrants   Exercise Price   Term (Years)   Value 
Outstanding - June 30, 2024   191,799,274   $0.24    3.21   $6,140,000 
Exercisable - June 30, 2024   191,799,274   $0.24    3.21   $6,140,000 
Granted   2,068,869   $0.10           
Exercised   -                
Cancelled/Forfeited   (1,871,800)  $0.16           
Outstanding - June 30, 2025   191,996,343   $0.05    2.21   $- 
Exercisable - June 30, 2025   191,996,343   $0.05    2.21   $- 
Granted   6,000,000   $0.10           
Exercised   (3,844,697)  $0.03           
Cancelled/Forfeited   (500,000)  $0.50           
Outstanding - March 31, 2026   193,651,646   $0.05    1.55   $- 
Exercisable - March 31, 2026   193,651,646   $0.05    1.55   $- 
Schedule of Fair Value of Warrant

The fair value of the warrant was estimated at $258,723 using the Black-Scholes option pricing model with the following assumptions:

 

Stock Price  $0.05 
Exercise price  $0.10 
Expected term (years)   5 
Expected volatility   183%
Expected dividends   0%
Risk free interest rate   3.72%